Genex and catalytica launch joint feasibility study

Nil

a view to strengthening

and developing

existing national and international Burch’s address

its

links. Dr.

is to be found under the

three venture short-term

capital

firms to conduct

feasibility

a

study to identify new

products or processes

that advantageous-

list of correspondents.

ly combine

their technologies.

If the feasi-

West German Catalyst Plant Expanded

pleted by the end of the year, is successful,

bility study, which is scheduled

According to Oil Gas J. (87(38)(1989) 43), The Davison manufacturing

European

operation

Co. has completed

the parties contemplate

additional

ment to fund product

development.

venture

FCC catalyst

of W.R. Grace &

bility study and development

FCC operations

the company’s

in

plans to expand

tion at Worms.

Davison

zeolite produc-

installed

manufacturing

steps to enable

ture of FCC catalysts

pharmaceutical,

in all

products verse

manufac-

possible

The latest project

with

vative products,

a new family of

technology

chemical treatment lumination,

214G,

and designed

protein

combining

and hydrothermal

dea-

to boost motor

research, separation

capabilities,

mercializes

duced Super Resoc, a new catalyst, as the

cess

successor

molecular

FCC catalyst.

its best known Eu(Source:

company

API Ab-

stracts 36, Oct. 9, 1989)

to design,

products

pro-

for the

and commercial

bio-

marketplace. designs, develops proprietary

technologies

catalysts

based

design

on

and comand proadvanced

that are economically

and environmentally duct areas include

Launch Joint Fea-

bio-

that uses proprietary expertise

diagnostic

cialty chemicals Genex And Catalytica

is

tech-

and market specialized

Catalytica

known as the M series. Davison also intro-

ropean

and

than

chemical is an applied

teins and affinity protein

is a new family of catalysts

to Resoc-I,

Corporation

manufacture,

octane barrels when used in FCC catalysts. matrix cracking

effects

traditional

engineering

Also available with variable

and other fine of biological

niques alone. Genex

including

inthe

to make

at lower cost or with fewer ad-

of several inno-

named

are

will be used to make

environmental

will also allow manufacture USY zeolites

Catalytica

specialty

chemical techniques

to tighter specifica-

tions and consistency.

funding

of novel processes

chemicals. A combination

state-of-

the-art control and process equipment

the strengths of Genexand development

capacity

from 20,000 to 45,000 tonnes per year. The company

The

the feasi-

The joint venture is designed to leverage

the first stage of a major capital spending raises

firms providing

Enterprise Associates.

of its plant in Worms (F.R.G.). The project,

Europe,

capital

invest-

the Mayfield Fund, Primus Capital and New

a $25 million expansion

program for Davison’s

to be com-

advantageous. commodity

Pro-

and spe-

and energy-related

pro-

ducts.

sibility Study Some Recent Articles The following

is a condensed

version of

a recent press release. Genex

Corporation

and Catalytica,

The following (NASDAQ/GNEX)

Inc. have announced

they have entered

into an agreement

applied catalysis -Volume

that

API Abstracts

with

lysis.

57 No. 2 -

is a listing of some of the

items which have recently been listed in the

15 January

1990

Series, Catalysts

and Cata-